Our Work
Latham Advises Archimed on Acquisition of Instem
September 4, 2023
London team represents global healthcare investment firm in the deal.
Latham & Watkins has advised Archimed, a global investment firm focused on the healthcare industries, on its £203 million recommended cash offer for Instem, a technology services company for drug development in the global life sciences market.
The Latham team was led by London corporate partners Farah O’Brien and Douglas Abernethy, with associates Harry Redford, Alice Drayton, and Venice Ma.